|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$82,075.89 |
2.84% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$78,542.40 |
2.72% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$74,807.34 |
2.59% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,573.80 |
2.54% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$72,624.78 |
2.51% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$71,482.52 |
2.47% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$68,464.98 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
184 |
$68,230.88 |
2.36% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,130.40 |
2.32% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$66,180.11 |
2.29% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$65,787.03 |
2.28% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$65,924.21 |
2.28% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$64,882.25 |
2.24% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$64,557.56 |
2.23% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$63,868.09 |
2.21% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$63,896.54 |
2.21% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$63,167.04 |
2.18% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$62,392.11 |
2.16% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$62,122.28 |
2.15% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,579.66 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$60,111.80 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$59,135.16 |
2.04% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$59,007.45 |
2.04% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$58,636.40 |
2.03% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$58,507.12 |
2.02% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,374.00 |
2.02% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$57,865.50 |
2.00% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,337.00 |
1.95% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$56,134.44 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,801.05 |
1.93% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$55,533.40 |
1.92% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$55,124.15 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$55,357.64 |
1.91% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,853.31 |
1.90% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$53,807.76 |
1.86% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$52,541.96 |
1.82% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,624.31 |
1.82% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,953.78 |
1.76% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$50,788.34 |
1.76% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$49,770.78 |
1.72% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$49,557.87 |
1.71% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,226.00 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$47,679.00 |
1.65% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$45,914.58 |
1.59% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,130.27 |
1.56% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$44,473.71 |
1.54% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$44,289.70 |
1.53% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,036.35 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$37,985.53 |
1.31% |
| US Dollar |
$USD |
|
14,881 |
$14,880.63 |
0.51% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|